Tris(2,2'-bipyridine)nickel(II) bromide, 95%, 25g

Sophoridine, 97.0%, 1g

5-Bromonicotinamide>98.0%(GC)5g

N-BOC-N-CYCLOHEXYLGLYCINE, 95.0%, 1g

tert-Butyl (6-methylpyridin-2-yl)carbamate, 95.0%, 100g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)propanoic acid, 97%, 10g

Methyl 3-bromo-2-fluoroisonicotinate, 98%, 1g

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID, 95.0%, 1g

Solución de formaldehído, 1 l.

Ethyl 4-methylpiperidine-4-carboxylate hydrochloride, 95.0%, 10g

N-[(3-methyl-2-thienyl)methyl]-1-butanamine hydrochloride, 95.0%, 1g

(5-Chloro-2-(methylthio)phenyl)boronic acid, 98%, 1g

(R)-tert-Butyl 3-[(2-methylpropyl)amino]piperidine-1-carboxylate, 95.0%, 1g